US Patent 7129241 Pyridazine derivatives
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+340 characters)
Article
Patent abstract
Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07129241 Pyridazine derivatives US Patent 7129241 Pyridazine derivatives
Infobox
Patent Number
0712924100
Patent Number
712924100
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071292410
Date of Patent
October 31, 2006
0Patent Application Number
105168760
Date Filed
May 12, 2003
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071292410
Date of Patent
October 31, 2006
0Patent Application Number
105168760
Date Filed
May 12, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07129241 Pyridazine derivatives
Infobox
Is a
Patent jurisdiction
Patent number
07129241
Date of patent
October 31, 2006
Patent application number
10516876
Date Filed
May 12, 2003
Patent primary examiner
Find more entities like US Patent 7129241 Pyridazine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
